Dennis Benjamin

Dr. Dennis Benjamin is the former SVP of Research at Seattle Genetics where he was a key developer of the company’s ADC technology and clinical pipeline. Prior to Seattle Genetics, he worked at Praecis Pharmaceuticals and Genetics Institute, advancing DNA encoded libraries and working in protein and small molecule discovery. Over his career, he has led teams that have discovered 25 biologics and small molecules that entered clinical trials and contributed to 4 drug approvals. He is currently an advisor and SAB member at several start-up biotechnology companies. Dr. Benjamin earned his B.S. in Chemistry at M.I.T., a Ph.D. in Medicinal Chemistry at U.C.S.F., and was a Hitchings-Elion Postdoctoral fellow at the University of Oxford.